RE:RE:RE:RNAiYeah, zwerp, you've said for a long time that the technology is no good, even though that opinion is contradicted by deals with J&J and others who have scientists who are far more capable of assessing xB3 than we are.
Instead of just saying xB3 is no good, can you give us the information and thought processes you used to arrive at your opinions, please?
You might also address why other companies like Denali are pursuing receptor-mediated transcytosis technologies to move drugs across the BBB. Are they also wrong?
Although we're looking forward to you giving us a more thorough treatment of your opinions, zwerp, we also recognize the possibility that you're just blowing off frustration with blah, blah, blah, which I'm sure we would all accept as the most plausible explanation for your opinions.
I think we all would applaud the truth from you.
jd